酰胺基硫脲及其相关的杂环衍生物的研究 V:1-(β-吗啉丙酰基)-4-芳基氨基硫脲及其相关杂环衍生物的合成

研究了β-吗啉丙酰肼和一系列芳基异硫氰酸酯间的反应. 获得六个1-吗啉丙酰基-4-芳基氨基硫脲类化合物, 其中一些被环化得到5-吗啉乙基-4-芳基-三唑啉-5-硫酮和2-芳胺基-5-(β-吗啉乙基)-1,3,4-噻二唑. 这里有些化合物具有植物生理活性和抗结构活性.     

酰氨基硫脲及有关的杂环衍生物的研究 I:1-氰乙酰基-4-芳基氨基硫脲及有关的杂环衍生物的合成

合成了九个1-氰乙酰基-4-芳基氨基硫脲类化合物和四个3-氰甲基-4-芳基-1,2,4-三唑啉与硫酮类化合物和四个2-苯基氨基-5-取代-1,3-噻二唑类化合物.并初步研究了这些化合物的抗结核菌活性和植物生长促进作用.     

酰氨基硫脲及其相关杂环衍生物的研究II.1-[5-(α-萘)-2H-四唑-2-乙酰[-4-苯基氨基硫脲及其相关环衍生物的合成

本文合成了1-[5-(α-萘)-2-H-四唑2-乙酰]-4-苯基氨基硫脲5,以及由5衍生的环化产物3-[5-(α-萘)-2H-四唑2-甲撑]-4-苯基-1,2,4-三咪啉-5-硫酮6,2-苯胺基-5-[5-(α-萘)-2H-四唑-2-甲撑]-1,3,4-噻二唑7及2-苯胺基-5-[5-(α-萘)-2H-四唑-2-甲撑]-1,3,4-二唑8.它们的结构均通过元素分析,红外光谱,核磁共振及质谱鉴定.其药理实验正在进行中.初步实验表明,5及6对小麦生长有较强的促进作用.     

酰氨基硫脲及其相关的杂环衍生物的研究——Ⅴ.1-(β-吗啉丙酰基)-4-芳基氨基硫脲及其相关杂环衍生物的合成

前文已报道某些1-酰基-4-取代氨基硫脲及其相关杂环衍生物具有广泛的生理活性,如抗结核,抗真菌,解痉挛及促进植物生长等功效。为进一步观察酰氨基硫脲及其杂环衍生物的有关活性,我们以β-吗啉丙酰肼(1)同一系列芳基异硫氰酸酯(2)进行反应,试图制得各种1-(β-吗啉丙酰基)-4-取代芳基氨基(3),并研究3在酸或碱性条件下的环化     

酰氨基硫脲及其相关杂环衍生物的研究 Ⅲ.1-(5-甲基异(口恶)唑-3-甲酰基)-4-芳基氨基硫脲及其相关杂环衍生物

前文报道了某些酰氨基硫脲及其相关杂环衍生物具有抗结核及促进植物生长的功效.我们试图通过5-甲基异噁唑-3-甲酰肼(1)与芳基异硫氰酸酯(2)的反应,制备一系列新的1-(5-甲基异噁唑-3-甲酰基)-4-取代氨基硫脲(3a-3h),并研究3在不同条件下环化的可能性.1的制备及其抗麻疯病的功效已有报道,但1与2的反应迄今未见报道.我们将1与2程95％的乙醇中进行反应,得到了预期的3及其衍生物3a-3h.     

酰氨基硫脲及相关杂环衍生物研究（XXV）

通过５－氨基－１－（４＇－氯苯基－４－甲酰肼基－１，２，３－三唑与芳基异硫氰酸酯的反应，合成了１３种新的１－［５＇－氨基－１＇－（４＇＇－氯苯基）－１＇，２＇，３＇－三唑－４＇－甲酰基］－４－芳基氨基硫脲类化全物３ａ－１，经元素分析，ＩＲ，ＨＮＭＲ以及ＭＳ确证其结构。     

酰氨基硫脲及其相关杂环衍生物的研究——Ⅱ.1-[5-(α-萘)-2 H-四唑-2-乙酰]-4-苯基氨基硫脲及其相关杂环衍生物的合成

本文合成了1-[5-(α-萘)-2 H-四唑-2-乙酰]-4-苯基氨基硫脲5,以及由5衍生的环化产物3-[5-(α-萘)-2 H-四唑-2-甲撑]-4-苯基-1,2,4-三唑啉-5-硫酮6,2-苯胺基-5-[5-(α-萘)-2 H-四唑-2-甲撑]-1,3,4-噻二唑7及2-苯胺基-5-[5-(α-萘)-2 H-四唑-2-甲撑]-1,3,4-(口恶)二唑8。它们的结构均通过元素分析,红外光谱,核磁共振及质谱鉴定。其药理实验正在进行中。初步实验表明,5及6对小麦生长有较强的促进作用。     

酰氨基硫脲及有关的杂环衍生物的研究 Ⅰ. 1-氰乙酰基-4-芳基氨基硫脲及有关的杂环衍生物的合成

文献报道一些酰氨基硫脲及有关的杂环衍生物,如1,2,4-三唑,1,3,4-噻二唑,具有一定程度的促进植物生长的功效。Cathey亦指出,含有C-C-N-N骨架的有机分子对植物有促进生长的作用。某些含有硫脲基团的有机化合物还具有抗结核等生理活性。为了研究含有这两种活性基团的化合物的生理活性,我们以氰乙酰肼(1)同芳基(取代芳基)异硫氰酸酯(2a-2i)进行反应,制得了九个1-氰乙酰基-4-芳基(取代芳基)氨基硫脲化合物(3a-3i)。     

芳杂环二腈及其聚合物VII含喹啉环二腈异构体的合成及分离

氰基邻苯二胺1与对-溴苯基乙二醛2反应,可得到喹啉衍生物3和4,由此可进一步制得含喹啉环的二腈5和6.3和4以及6均互为异构体.合成化合物5后,进一步确定了3,4和6的结构.     

Gas-phase pyrolysis in heterocyclic synthesis. Gas-phase elimination reactions of some substituted aminoazoles

Gas-phase pyrolyses of ethyl N-(5-cyanomethyl-1,3,4-thiadiazol-3-yl)carbamate ( 1 ), 1-benzoyl-3-(3-methylpyrazol-5-yl)thiourea ( 2 ), 1-benzoyl-3-(5-methylisoxazol-3-yl)thiourea ( 3 ), and 1-acetyl-3-(3-phenyl-pyrazol-5-yl)thiourea ( 4 ) have been studied. These reactions were homogeneous and unimolecular. The kinetics obeyed the first-order rate equation. Utilization of this pyrolytic reaction in heterocyclic synthesis is considered, and mechanistic information has been obtained from kinetic data and product analysis using an on-line pyrolysis GC-MS technique. The physical constants of four new substituted aminoazoles are also described. © 1997 John Wiley & Sons, Inc.     

Bis heterocycles as potential chemotherapeutic agents. X. Synthesis of bis(4-arylthiosemicarbazido)-, bis(2-arylamino-1,3,4-thiadiazol-5-yl) and bis(4-aryl-1,2,4-triazolin-3-thione-5-yl)pentanes and related compounds

Synthesis of several bis(4-arylthiosemicarbazido- 1 , bis(2-arylamino-1,3,4-thiadiazol-5-yl)- 5 and bis(4-aryl-1,2,4-triazolin-3-thione-5-yl)- 2 pentanes is described. Sulphides 3 and sulphones 4 are also prepared from 2 by alkylation and subsequent oxidation with hydrogen peroxide respectively.     

Synthesis and characterization of mono- and bicyclic heterocyclic derivatives containing 1,2,4-triazole, 1,3,4-thia-, and -oxadiazole rings

A series of new N- and S-substituted 1,3,4-oxadiazole derivatives were synthesized. 5-Pyridin-3-yl-3-[2-(5-thioxo-4,5-dihydro-l,3,4-thiadiazol-2-yl)ethyl]-1,3,4-oxadiazole-2(3H)-thione and 5-[(5-(pyridin-3-yl)-1,3,4-oxadiazol-2-ylthio)methyl]-N-phenyl-1,3,4-thiadiazol-2-amine were formed by cyclization of 3-(5-pyridin-3-yl-2-thioxo-1,3,4-oxadiazol-3(2H)-ylpropanimidohydrazide and 2-[(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)thio]thiosemicarbazide with CS₂ and H₂SO₄. On the other hand, a number of new bicyclic 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives were synthesized. 6-Pyridin-3-ylbis[1,2,4]‐triazolo[3,4-b:4′,3′-d][1,3,4]thiadiazole-3(2H)-thione was synthesized by reaction of 6-(hydrazino)-3-pyridine-3-yl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole with CS₂/KOH/EtOH. The structures of the newly synthesized compounds were elucidated by the spectral and analytical data IR, Mass, and ¹H NMR spectra. Correspondence: Adel A.-H. Abdel-Rahman, Department of Chemistry, Faculty of Science, Menoufia University, Shebin El-Koam, Egypt; Wael A. El-Sayed, National Research Centre, Department of Photochemistry, Cairo, Egypt.     

The use of umbelliferone in the synthesis of new heterocyclic compounds

New coumarin derivatives, namely 7-[(5-amino-1,3,4-thiadiazol-2-yl)methoxy]-2H-chromen-2-one, 5-[(2-oxo-2H-chromen-7-yloxy)methyl]-1,3,4-thiadiazol-2(3H)-one, 2-[2-(2-oxo-2H-chromen-7-yloxy)acetyl]-N-phenylhydrazinecarbothioamide, 7-[(5-(phenylamino)-1,3,4-thiadiazol-2-yl)methoxy]-2H-chromen-2-one and 7-[(5-mercapto-4-phenyl-4H-1,2,4-triazol-3-yl)methoxy]-2H-chromen-2-one were prepared starting from the natural compound umbelliferone. The newly synthesized compounds were characterized by elemental analysis and spectral studies (IR, 1H-NMR and 13C-NMR).     

Environmentally benign synthesis of sydnone containing 1,3,4-thiadiazines under microwave and solvent-free conditions

Novel, convenient and benign synthesis of 2-arylamino-5-(3′-arylsydnone-4-yl)-1,3,4-thiadiazines 3a-l by the interaction of 3-substituted-4-bromoacetyl sydnones 1 with substituted thiosemicarbazides 2 under MW irradiation and solvent-free condition is described.     

Studies on heterocyclic primary amines,I. reaction of 2-amino-5-aryl-1,3,4-oxadiazoles with phosphorus pentachloride

Stable N-(5-aryl-1,3,4-oxadiazol-2-yl)phosphorimidic trichlorides (II) are obtained by refluxing 2-amino-5-aryl-1,3,4-oxadiazoles (I) with one equivalent of phosphorus pentachloride in dry benzene. The reactions of the phosphorimidic trichlorides were also studied.     

Synthesis and single cell pharmacology of potential heterocyclic bioisosteres of the excitatory amino acid antagonist glutamic acid diethyl ester

A series of heterocyclic analogues of glutamic acid diethyl ester (GDEE), an antagonist at central excitatory amino acid receptors, have been synthesized and tested biologically. (RS)-Ethyl alpha-amino-alpha-(3-ethoxyisoxazol-5-yl)acetate (7), (RS)-ethyl 2-amino-3-(3-ethoxy-5-methylisoxazol-4-yl)propionate (16) and closely related analogues were synthesized. Compound 7, a diethyl derivative of the naturally occurring excitatory amino acid ibotenic acid (IBO), was synthesized from 3-hydroxy-5-methylisoxazole (1) via 3-ethoxyisoxazol-5-ylacetic acid (5) and its ethyl ester. Nitrosation of this ester followed by catalytic reduction gave 7. The ethyl ester of IBO, 9, was synthesized in a similar manner from 3-benzyloxyisoxazol-5-ylacetic acid (8). Ethyl derivatives of the synthetic excitatory amino acid 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) were synthesized from 3-hydroxy-4,5-dimethylisoxazole (10) through a diethyl acetylaminomalonate derivative, which upon deprotection gave the 3-ethoxy derivative of AMPA (15). Esterification of 15 gave the diethyl derivative 16 and the ethyl ester of AMPA (18) as well as N-ethylated derivatives of AMPA, 21 and 22 were synthesized. The final products were tested microelectrophoretically. The derivatives 7, 9, 15, 16 and 18 were weak and non-selective excitatory amino acid antagonists, whereas 21 and 22 were found to be inactive.     

Synthesis and biological evaluation of novel 2-(substituted isoxazol-4-yl)-5-arylamino-1,3,4-oxadiazoles

A series of 2-(5-methyl-3-(4-chloro/trifluoromethylphenyl)isoxazol-4-yl)-5-arylamino-1,3,4-oxadiazoles were synthesized from 4-chloro/trifluoromethyl benzaldehyde, ethyl acetoacetate, hydroxylamine hydrochloride, hydrazine hydrate, and aryl isocyanate by multi-step reactions. The structures of the target compounds were elucidated by IR, ¹H NMR, MS, and elemental analysis. All these compounds were tested for in vitro antifungal activities against Botrytis cinerea and Rhizoctonia cerealis by the mycelium growth rate method, and the results indicated that some compounds displayed high antifungal activity against Botrytis cinerea.     

The Synthesis And Crystal Structure Of 3-[5-Methyl-1-(4-Methylphenyl)-1,2,3-Triazol-4-yl]-s-Triazolo[3,4-b]-1,3,4-Thiadiazole

Likewise the 1,3,4-thiadiazole nucleus which incorporates an N-C-S linkage exhibits a large number of biological activities^[1]. The fused 1,3,4-triazolo[3,4-b]-1,3,4-thiadiazoles derivatives show various biological effects, such as antifungal^[2], antibacterial, hypotensive and CNS depressant activities^[3]. The novel 3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole 6 have been synthesized by the condensation of 4-amino-5-mercapto-3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazole 5 with formic acid in the presence of phosphorus oxychloride. The compound 5 was prepared from 4 that was prepared from 1 throng 2 and 3. Recently, we obtained the crystal structure of the novel compound 3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole, C₁₄H₁₂Cl₃N₇S, Mr=416.72, Crystallizes in the triclinic space group with unit cell parameters a=9.049(2), b=10.486(3), c=10.843(2)Å, α=116.79(2), β=93.83(2), γ-100.64(3)°. V=889.3(4)ų, Z=1, Dx-0.778 Mgm^-3. The final R was 0.0535.